In the late summer, Arriello commissioned a comprehensive survey of European and US pharma companies’ initial experiences of the EMA’s new centralised clinical trials information system (CTIS). The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback